Sign in
TerminatedNo phase

The Decline in Walking Performance in Adults With Cerebral Palsy - Influence of Performance Fatigability

Key facts

Who runs it
Centre Hospitalier Universitaire de Saint Etienne
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
30 people enrolled
Started
2 May 2023
Ended
10 Jul 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Fatigability assessment
Record updated
26 October 2024
Why it stopped
Lack of inclusion

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Common for CP and healthy volunteers:
  • Capable of walking for six minutes without stopping
  • Capable of consenting to the tests; Specific for the CP group
  • GMFCS I or II at age 18
  • Spastic diplegic cerebral palsy

Who cannot take part

  • Accompanying diseases not allowing for the test setup
  • Counter-indications to the test procedures
  • Mental retardation or intelligence quotient (IQ) below 80
  • Major surgeries altering performance in the last six months
  • Injection of botulin altering maximal force production in the last three months
  • Refusing to sign the consent form

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Due to an early brain injury occurring in antenatal or postnatal, cerebral palsy (CP) causes alteration in motor function with posture and gait disorders. It is commonly observed motor performance degradation during adulthood, and the underlying pathophysiology remains poorly known.

The 2 groups in the trial

  • Patients with cerebral palsyTreatment being tested

    A specially adapted recumbent cycle ergometer with the ability to quickly transform into an isometric dynamometer will be used to assess fatigability development during a task to failure. Throughout the task, which consists of blocks of 3 minutes, neuromuscular assessments will take place to determine the evolution of fatigability and its peripheral and central determinants.

    Treatment: Fatigability assessment

  • Healthy peopleExisting treatment, for comparison

    A specially adapted recumbent cycle ergometer with the ability to quickly transform into an isometric dynamometer will be used to assess fatigability development during a task to failure. Throughout the task, which consists of blocks of 3 minutes, neuromuscular assessments will take place to determine the evolution of fatigability and its peripheral and central determinants.

    Treatment: Fatigability assessment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
26 October 2024